Lebrikizumab Improved Skin Signs, Quality of Life, and Showed High Levels of Patient Satisfaction in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis and Skin of Color. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 2, p. s549, 2025. DOI: 10.25251/skin.10.supp.549. Disponível em: https://skin.dermsquared.com/skin/article/view/3297. Acesso em: 1 may. 2026.